17.53
price down icon1.74%   -0.31
pre-market  プレマーケット:  16.85   -0.68   -3.88%
loading
前日終値:
$17.84
開ける:
$17.69
24時間の取引高:
2.68M
Relative Volume:
0.96
時価総額:
$2.22B
収益:
$631.73M
当期純損益:
$-239.78M
株価収益率:
-8.6782
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
-1.90%
1か月 パフォーマンス:
+2.63%
6か月 パフォーマンス:
+64.60%
1年 パフォーマンス:
+8.54%
1日の値動き範囲:
Value
$17.41
$18.38
1週間の範囲:
Value
$17.06
$18.38
52週間の値動き範囲:
Value
$6.78
$20.34

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1124)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,306
Name
Twitter
@10xgenomics
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

TXG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Health Information Services icon
TXG
10 X Genomics Inc
17.53 2.26B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
229.16 38.14B 3.08B 860.33M 1.35B 5.1463
Health Information Services icon
TEM
Tempus Ai Inc
75.07 13.50B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
45.04 8.50B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
95.73 7.97B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
BTSG
Brightspring Health Services Inc
35.20 6.39B 11.99B 24.18M 234.31M 0.2956

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-02 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-09-11 開始されました Piper Sandler Neutral
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
Dec 08, 2025

10x Genomics $TXG Shares Bought by Jump Financial LLC - MarketBeat

Dec 08, 2025
pulisher
Dec 07, 2025

Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - Finviz

Dec 07, 2025
pulisher
Dec 05, 2025

Why 10x Genomics Inc. stock appeals to analystsMarket Risk Summary & Long-Term Capital Growth Ideas - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Russell Investments Group Ltd. Increases Stock Position in 10x Genomics $TXG - MarketBeat

Dec 04, 2025
pulisher
Dec 03, 2025

Is 10x Genomics Inc. (1KJ) stock among top earnings playsJuly 2025 Highlights & Low Risk Entry Point Tips - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Market Fear: Is CPSR stock trading at a premium valuation2025 Performance Recap & Fast Moving Stock Trade Plans - BỘ NỘI VỤ

Dec 02, 2025
pulisher
Dec 02, 2025

10x Genomics Comments on Second UPC Preliminary Injunction Decis - GuruFocus

Dec 02, 2025
pulisher
Dec 02, 2025

TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target - GuruFocus

Dec 02, 2025
pulisher
Dec 01, 2025

Tumor Transcriptomics Research Report 2025: An $8.71 Billion Market by 2030, Driven by Rising Global Cancer Prevalence and Advancements in Genomic Sequencing Technologies - GlobeNewswire Inc.

Dec 01, 2025
pulisher
Nov 30, 2025

TXG Technical Analysis & Signals — Is 10x Genomics, Inc. Stock a Buy or Sell? - Meyka

Nov 30, 2025
pulisher
Nov 30, 2025

Is 10x Genomics Inc. stock safe for conservative investors2025 Breakouts & Breakdowns & Weekly Return Optimization Alerts - BỘ NỘI VỤ

Nov 30, 2025
pulisher
Nov 29, 2025

Aug Levels: Why 10x Genomics Inc. stock could benefit from AI revolutionJuly 2025 Institutional & Verified Technical Trade Signals - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 27, 2025

What sentiment indicators say about 10x Genomics Inc. stockQuarterly Profit Summary & Reliable Breakout Forecasts - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 27, 2025

10x Genomics to Acquire Scale Biosciences (PR Newswire) - Aktiellt

Nov 27, 2025
pulisher
Nov 26, 2025

Buy Signal: Is 10x Genomics Inc. stock safe for conservative investorsWeekly Earnings Recap & Reliable Momentum Entry Alerts - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 26, 2025

How 10x Genomics Inc. stock responds to policy changes2025 Volatility Report & Risk Managed Trade Strategies - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 25, 2025

10x Genomics Insider Sold Shares Worth $251,936, According to a Recent SEC Filing - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

[Form 4] 10x Genomics, Inc. Insider Trading Activity - Stock Titan

Nov 25, 2025
pulisher
Nov 25, 2025

Pres Hindson Surrenders 8,283 Of 10X Genomics Inc [TXG] - TradingView

Nov 25, 2025
pulisher
Nov 24, 2025

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know - Finviz

Nov 24, 2025
pulisher
Nov 24, 2025

CEO Saxonov Files To Sell 13,096 Of 10X Genomics Inc [TXG] - TradingView

Nov 24, 2025
pulisher
Nov 24, 2025

CFO Taich Files To Sell 11,312 Of 10X Genomics Inc [TXG] - TradingView

Nov 24, 2025
pulisher
Nov 24, 2025

Q3 2025 10X Genomics Inc Earnings Call Transcript - GuruFocus

Nov 24, 2025
pulisher
Nov 23, 2025

10x Genomics, Inc. (NASDAQ:TXG) Q4 2024 Earnings Call Transcript - MSN

Nov 23, 2025
pulisher
Nov 23, 2025

10x Genomics, Inc.Common Stock (NQ: TXG - Markets Financial Content

Nov 23, 2025
pulisher
Nov 23, 2025

Is 10x Genomics’ (TXG) New Asia-Pacific Consortium Key to Sustaining Its Leadership in Spatial Genomics? - Yahoo Finance

Nov 23, 2025
pulisher
Nov 22, 2025

10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - MSN

Nov 22, 2025
pulisher
Nov 21, 2025

Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know - Yahoo Finance

Nov 21, 2025
pulisher
Nov 21, 2025

10X Genomics stock hits 52-week high at 17.7 USD By Investing.com - Investing.com India

Nov 21, 2025
pulisher
Nov 21, 2025

10X Genomics stock hits 52-week high at 17.7 USD - Investing.com

Nov 21, 2025
pulisher
Nov 20, 2025

Spatial Biology Market Analysis and Forecast, 2025-2035: - GlobeNewswire

Nov 20, 2025
pulisher
Nov 20, 2025

Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum - Yahoo Finance

Nov 20, 2025
pulisher
Nov 20, 2025

How 10x Genomics Inc. (1KJ) stock trades pre earnings2025 Support & Resistance & Reliable Breakout Forecasts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Total liabilities & shareholders' equities of 10x Genomics Inc Class A – HAM:1KJ - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

Is 10x Genomics Inc. stock a buy before product launchesJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium - StreetInsider

Nov 18, 2025
pulisher
Nov 18, 2025

3 Reasons to Avoid TXG and 1 Stock to Buy Instead - Yahoo Finance

Nov 18, 2025
pulisher
Nov 16, 2025

10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN

Nov 16, 2025
pulisher
Nov 16, 2025

TXG (10x Genomics) Inventory-to-Revenue : 0.44 (As of Sep. 2025) - GuruFocus

Nov 16, 2025
pulisher
Nov 15, 2025

10x Genomics Announces Chief Legal Officer Retirement - The Globe and Mail

Nov 15, 2025
pulisher
Nov 14, 2025

10x Genomics GC Who Led Rule Of Law Effort To Retire In '26 - Law360

Nov 14, 2025
pulisher
Nov 14, 2025

There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st

Nov 14, 2025
pulisher
Nov 14, 2025

10x Genomics, Inc. Announces Executive Changes, Effective January 1, 2026 - MarketScreener

Nov 14, 2025
pulisher
Nov 14, 2025

10X Genomics Stock Soars 17.31%, Hits Intraday High of $15.26 - Markets Mojo

Nov 14, 2025
pulisher
Nov 13, 2025

10x Genomics Inc Class A Earnings and Revenue – HAM:1KJ - TradingView

Nov 13, 2025
pulisher
Nov 13, 2025

How 10x Genomics Inc. (1KJ) stock valuation compares with sectorChart Signals & Safe Entry Point Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Why 10x Genomics Inc. (1KJ) stock attracts wealthy investorsSell Signal & Verified Stock Trade Ideas - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 - Eastern Progress

Nov 13, 2025
pulisher
Nov 13, 2025

TXG announces CLO retirement; Randy Wu to serve as General Counsel - Stock Titan

Nov 13, 2025
pulisher
Nov 12, 2025

10x Genomics, Inc. (TXG) Stock Price Quote Today & Current Price Chart - Capital.com

Nov 12, 2025
pulisher
Nov 12, 2025

10x Genomics (TXG): Assessing Valuation After Strong Earnings, Upbeat Forecast and New Product Launch - Yahoo Finance

Nov 12, 2025

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.07
price up icon 4.47%
$24.18
price up icon 1.64%
$49.69
price up icon 0.44%
health_information_services WAY
$30.40
price down icon 0.10%
$35.20
price down icon 0.65%
大文字化:     |  ボリューム (24 時間):